Celldex Therapeutics
CLDX
#4623
Rank
A$3.23 B
Marketcap
A$41.24
Share price
-1.68%
Change (1 day)
7.40%
Change (1 year)

Earnings for Celldex Therapeutics (CLDX)

Earnings in 2026 (TTM): -A$0.49 Billion

According to Celldex Therapeutics's latest financial reports the company's current earnings are A$0.15 Million. In 2025 the company made an earning of -A$0.44 Billion a decrease over its 2024 earnings that were of -A$0.3 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Celldex Therapeutics from 1986 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.49 Billion11.37%
2025 -A$0.44 Billion47.31%
2024 -A$0.3 Billion37.34%
2023 -A$0.22 Billion32.63%
2022 -A$0.17 Billion54.88%
2021 -A$0.11 Billion39.49%
2020 -A$74.37 Million-9.08%
2019 -A$81.8 Million-28.64%
2018 -A$0.12 Billion-30.11%
2017 -A$0.17 Billion-17.75%
2016 -A$0.2 Billion4.5%
2015 -A$0.2 Billion4.09%
2014 -A$0.19 Billion51.57%
2013 -A$0.13 Billion40.1%
2012 -A$86.33 Million
2010 -A$1.88 Million-96.59%
2009 -A$54.91 Million
2006 -A$33.56 Million
2004 -A$20.38 Million15.75%
2003 -A$17.61 Million-18.69%
2002 -A$21.65 Million-41.22%
2001 -A$36.83 Million59%
2000 -A$23.17 Million27.65%
1999 -A$18.15 Million53.12%
1998 -A$11.86 Million2.6%
1997 -A$11.56 Million-33.62%
1996 -A$17.41 Million-1.69%
1995 -A$17.71 Million22.92%
1994 -A$14.41 Million-0%
1993 -A$14.41 Million
1991 -A$8.86 Million90.32%
1990 -A$4.66 Million10.71%
1989 -A$4.21 Million833.33%
1988 -A$0.46 Million-400%
1987 A$0.15 M-125%
1986 -A$0.61 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$10.45 B-2,238.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$16.57 B-3,491.97%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$10.73 B-2,295.78%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
-A$4.21 Million-99.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-A$1.19 Billion 142.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
A$0.22 B-146.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-A$0.3 Billion-40.28%๐Ÿ‡บ๐Ÿ‡ธ USA